-
Targeting the BCR signalosome in B cell malignancies
de Rooij, M. F. M., 2017, 209 p.Research output: PhD thesis › Thesis, fully internal
-
Ibrutinib and idelalisib target B cell receptor- but not CXCL12/CXCR4-controlled integrin-mediated adhesion in Waldenström macroglobulinemia
de Rooij, M. F. M., Kuil, A., Kraan, W., Kersten, M. J., Treon, S. P., Pals, S. T. & Spaargaren, M., 2016, In: Haematologica. 101, 3, p. e111-e115Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
Ibrutinib and idelalisib synergistically target BCR-controlled adhesion in MCL and CLL: a rationale for combination therapy
de Rooij, M. F. M., Kuil, A., Kater, A. P., Kersten, M. J., Pals, S. T. & Spaargaren, M., 2015, In: Blood. 125, 14, p. 2306-2309Research output: Contribution to journal › Comment/Letter to the editor* › Academic
- All publications
